Metastatic breast cancer patient perceptions of somatic tumor genomic testing
Elizabeth Adams(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Daniel G. Stover(Harvard University), Mahmoud Abdel‐Rasoul(The Ohio State University), Robert Wesolowski(The Ohio State University Wexner Medical Center), James L. Chen(Mayo Clinic), Nicole Williams(The Ohio State University), Erin Macrae(McGill University), Amanda E. Toland(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Robert Pilarski(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Katharine A. Collier(The Ohio State University), Anne M. Noonan(The Ohio State University), Clara N. Lee(University of North Carolina at Chapel Hill), Jeffrey VanDeusen(The Ohio State University), Susan Gillespie(The Ohio State University), Bhuvaneswari Ramaswamy(The Ohio State University), Mathew Cherian(The Ohio State University Wexner Medical Center), Raquel E. Reinbolt(The Ohio State University), Maryam B. Lustberg(Yale Cancer Center), Sarah Asad(The Ohio State University), Sagar Sardesai(The Ohio State University), Charles L. Shapiro(Tisch Hospital), Leigha Senter(Lunenfeld-Tanenbaum Research Institute)
Cited by 16
Related Papers
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2014|1.2k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
|Journal of Clinical Oncology|2020|1.1k
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017
|Journal of the National Comprehensive Cancer Network|2016|660
Genetic/Familial High-Risk Assessment: Breast and Ovarian
|Journal of the National Comprehensive Cancer Network|2010|650